Cargando…

Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population

Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in genes coding for proteins involved in sarcomere function. The disease is associated with mitochondrial dysfunction. Evolutionarily developed variation in mitochondrial DNA (mtDNA), defining mtDNA haplogroups and haplogrou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagen, Christian M., Aidt, Frederik H., Hedley, Paula L., Jensen, Morten K., Havndrup, Ole, Kanters, Jørgen K., Moolman-Smook, Johanna C., Larsen, Severin O., Bundgaard, Henning, Christiansen, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734310/ https://www.ncbi.nlm.nih.gov/pubmed/23940792 http://dx.doi.org/10.1371/journal.pone.0071904

Ejemplares similares

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy
por: Hagen, Christian M., et al.
Publicado: (2015)

The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study
por: Hedley, Paula L, et al.
Publicado: (2011)

A Novel Myosin Essential Light Chain Mutation Causes Hypertrophic Cardiomyopathy with Late Onset and Low Expressivity
por: Andersen, Paal Skytt, et al.
Publicado: (2012)

Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting
por: Heradien, M, et al.
Publicado: (2007)

Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2
por: Christiansen, Michael, et al.
Publicado: (2014)

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008)

Complex spatio-temporal distribution and genomic ancestry of mitochondrial DNA haplogroups in 24,216 Danes
por: Bybjerg-Grauholm, Jonas, et al.
Publicado: (2018)

Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations
por: Heradien, Marshall, et al.
Publicado: (2009)

Dysfunctional mitochondrial respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model
por: Aidt, Frederik Heurlin, et al.
Publicado: (2013)

Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations
por: Duhn, Pernille Hurup, et al.
Publicado: (2017)

Schizophrenia-associated mt-DNA SNPs exhibit highly variable haplogroup affiliation and nuclear ancestry: Bi-genomic dependence raises major concerns for link to disease
por: Hagen, Christian M., et al.
Publicado: (2018)

Striving towards the ideal cardiac functional assessment strategy: the contribution of tissue Doppler, strain and strain rate imaging
por: Moolman-Smook, JC, et al.
Publicado: (2007)

Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch
por: Brink, PA, et al.
Publicado: (2009)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study
por: Jespersen, Camilla H B, et al.
Publicado: (2022)

Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume
por: Mills, Helen, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic Cardiomyopathy
por: Fernández-Caggiano, Mariana, et al.
Publicado: (2012)

Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy
por: Mouton, Jomien M, et al.
Publicado: (2015)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Case report: spontaneous coronary artery dissection and suspicion of takotsubo cardiomyopathy in a patient presenting with T-wave inversions, severe QTc prolongation, elevated cardiac biomarkers, and apical akinesia
por: Frederiksen, Kåre Peter, et al.
Publicado: (2020)

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Preterm birth, stillbirth and early neonatal mortality during the Danish COVID-19 lockdown
por: Hedley, Paula L., et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study
por: Marstrand, Peter, et al.
Publicado: (2021)

Platelet Activation in Cats with Hypertrophic Cardiomyopathy
por: Tablin, F., et al.
Publicado: (2014)

Translational investigation of electrophysiology in hypertrophic cardiomyopathy
por: Flenner, Frederik, et al.
Publicado: (2021)

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry
por: Veselka, Josef, et al.
Publicado: (2020)

MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome
por: Hedley, Paula L., et al.
Publicado: (2014)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_og1qko51v79j3vvfkc4g65m0e8